Wintrust Investments’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,355
Closed -$601K 339
2022
Q4
$601K Buy
28,355
+13,720
+94% +$284K 0.08% 190
2022
Q3
$298K Buy
+14,635
New +$291K 0.04% 305

Other funds holding BTAL

Wintrust Investments's BTAL Position: Q1 2023 in Review

Wintrust Investments sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2023, closing a stake of 28,355 shares — an estimated $601K sold.

Wintrust Investments first reported a position in BTAL in Q3 2022 and held it in 2 quarters. The position peaked at $601K in Q4 2022. 89 funds tracked by Wall St. Rank hold BTAL as of Q1 2023.

  • Wintrust Investments reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2023 after selling out during the quarter.
  • Wintrust Investments sold 28,355 AGF US Market Neutral Anti-Beta Fund shares in Q1 2023, an estimated $601K.
  • Wintrust Investments first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 2 quarters.
  • Wintrust Investments's AGF US Market Neutral Anti-Beta Fund position peaked at $601K in Q4 2022.
  • 89 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2023.

Based on Wintrust Investments's 13F filing for Q1 2023, filed 9 May 2023.